Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLEK.L Regulatory News (LEK)

  • There is currently no data for LEK

Lekoil Presentation at UBS Conference

17 Mar 2016 07:00

RNS Number : 3683S
Lekoil Limited
17 March 2016
 

 

 

Lekoil Limited

("Lekoil" or the "Company") 

Investor Presentation to UBS Conference 

Lekoil Limited (AIM: LEK) is pleased to report that Lekan Akinyanmi, Chief Executive Officer, will be presenting at the annual UBS Oil and Gas Conference being held today in London.

 

A full copy of the presentation is available on Lekoil's website at http://www.lekoil.com/index.php/investor-presentations.html. No material new information will be disclosed at the investor conference or in the presentation.

 

For further information, please visit www.lekoil.com or contact:

 

Lekoil Limited

Alfred Castaneda (Investor Relations)

 

+1 609 945 0805

+44 20 3434 5800

 

Strand Hanson Limited (Financial & Nominated Adviser)

James Harris / James Spinney / Ritchie Balmer

 

+44 20 7409 3494

 

Mirabaud Securities LLP (Joint Broker)

Peter Krens

 

+44 20 7878 3362

+44 20 7878 3447

BMO Capital Markets (Joint Broker)

Rupert Newall / Neil Haycock / Thomas Rider

 

+44 20 7236 1010

Tavistock (Financial PR)

Simon Hudson / Ed Portman / Merlin Marr-Johnson

 

+44 20 7920 3150

 

-ends-

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUNOORNRAOAUR
Date   Source Headline
17th May 20226:00 pmRNSLekoil
16th May 202210:11 amRNSOperational Update
16th May 20227:00 amRNSCorporate Update
11th May 20223:17 pmRNSNotice of GM
5th May 20227:00 amRNSLitigation summary & Response to Lekoil Nigeria
25th Apr 202211:31 amRNSRNS correction
19th Apr 202211:50 amRNSOperational Update
13th Apr 20227:00 amRNSCorporate Update
8th Apr 20227:00 amRNSResult of EGM
7th Apr 20224:06 pmRNSExtraordinary General Meeting Confirmation
7th Apr 202212:27 pmRNSCayman winding up petition
6th Apr 20229:13 amRNSNigerian injunction
1st Apr 20221:13 pmRNSLekoil Nigeria offer to purchase OPL 310 Loan
1st Apr 20227:00 amRNSCorporate Update
21st Mar 20225:59 pmRNSNotice of Extraordinary General Meeting
18th Mar 202212:43 pmRNSOperational Update
16th Mar 20221:01 pmRNSHolding(s) in Company
16th Mar 20221:00 pmRNSHolding(s) in Company
11th Mar 20224:51 pmRNSConvertible Facility update and issue of equity
11th Mar 20227:52 amRNSConvertible Facility update
9th Mar 20222:49 pmRNSConvertible Facility update
3rd Mar 202211:24 amRNSStrategic Investment and Structuring update
28th Feb 20221:58 pmRNSHolding(s) in Company
28th Feb 20221:50 pmRNSStrategic Investment and Restructuring
18th Feb 20229:18 amRNSOperational Update
16th Feb 20227:50 amRNSUpdate on legal claim
11th Feb 20227:00 amRNSHolding(s) in Company
21st Jan 20221:47 pmRNSDirector Loan - update of legal claims
19th Jan 202212:44 pmRNSDirector Loan - update of legal claims
18th Jan 202212:30 pmRNSOperational Update
18th Jan 20227:00 amRNSHolding(s) in Company
18th Jan 20227:00 amRNSHolding(s) in Company
6th Jan 20229:54 amRNSNotification of legal claim
24th Dec 20217:00 amRNSOperational Update
23rd Dec 20211:19 pmRNSOffer from Lekoil Nigeria
22nd Dec 20217:00 amRNSResult of AGM
15th Dec 20218:19 amRNSCorporate Update
7th Dec 20217:00 amRNSAnnual General Meeting attendance by telephone
6th Dec 20212:00 pmRNSCorporate update
26th Nov 202111:53 amRNSNotice of Annual General Meeting
25th Nov 202111:36 amRNSDirectorate Changes
18th Nov 20211:07 pmRNSOperational Update
27th Oct 202111:37 amRNSResults for six months ended 30 June 2021
18th Oct 202112:56 pmRNSResults for the year ended 31 December 2020
8th Oct 20215:29 pmRNSAnnual Accounts Update
1st Oct 20217:30 amRNSSuspension – Lekoil Limited
30th Sep 20217:00 amRNSSuspension of trading pending annual accounts
24th Sep 20213:36 pmRNSCivil Action
22nd Sep 20217:00 amRNSInterim Results Reporting Timeline
15th Sep 20211:00 pmRNSCorporate and Operational Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.